Form 8-K - Current report:
SEC Accession No. 0000950136-07-007239
Filing Date
2007-10-25
Accepted
2007-10-25 17:25:19
Documents
4
Period of Report
2007-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K file1.htm 8-K 32027
2 UNDERWRITING AGREEMENT file2.htm EX-1.1 229632
3 ebox.gif GRAPHIC 58
4 spacer.gif GRAPHIC 43
  Complete submission text file 0000950136-07-007239.txt   263863
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 071191618
SIC: 2836 Biological Products, (No Diagnostic Substances)